GlassScriptPhysician profile
Susan D Rivera
NPI 1114918786
$6,678.21
in general payments reported to CMS, 2019-2025
42 companies · $1,587 in 2025
The $1,587 reported for 2025 was more than what 91% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $823 · 2022: $1,621 · 2023: $1,277 · 2024: $1,370 · 2025: $1,587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,233.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,905.90 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $879.72 | 2021-2024 | |
| Lilly USA, LLC | $553.78 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Amgen INC. | $535.58 | 2023-2025 | Repatha, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $432.22 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Novartis Pharmaceuticals Corporation | $277.11 | 2022-2023 | |
| Pfizer INC. | $232.57 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $231.25 | 2021-2025 | Xifaxan |
| Phathom Pharmaceuticals, INC. | $198.95 | 2024-2025 | Voquezna |
| Ucb, INC. | $124.02 | 2021-2022 | |
| Exact Sciences Corporation | $119.60 | 2023-2025 | Cologuard Collection Kit |
| Neurocrine Biosciences, INC. | $95.37 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $90.70 | 2021-2023 | Rexulti |
| Xeris Pharmaceuticals, INC. | $86.25 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $75.06 | 2024-2025 | Caplyta |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.